Alabama State Lands Major Partnership to Help Build the Future of U.S. Pharmaceutical Manufacturing

MONTGOMERY, Ala. — Alabama State University is taking another significant step in expanding opportunities for its students beyond the classroom.

The HBCU has announced a strategic partnership with Callan JMB Inc. that will connect students and faculty to the company’s planned Atlas Complex, a 150-acre pharmaceutical manufacturing and medical logistics campus under development in Marion, Alabama.

The collaboration is designed to strengthen workforce development, applied research, and innovation while helping prepare the next generation of professionals for careers in pharmaceutical manufacturing, biotechnology, healthcare logistics, and supply chain management.

For Alabama State, the partnership carries added significance. The university was founded in Marion in 1867 before relocating to Montgomery, making the project a return to its historic roots while investing in the future of Alabama’s economy.

Under the agreement, ASU students will have access to internship opportunities, faculty-led research projects, and academic programs aligned with the growing pharmaceutical and life sciences industries. The initiative also aims to connect students directly with companies expected to establish operations within the Atlas Complex.

Callan JMB envisions the Atlas Complex as more than a manufacturing site. The campus is being developed as an integrated hub where pharmaceutical production, research, workforce training, quality assurance, and logistics operate together under one ecosystem. Company officials believe the project will help strengthen domestic pharmaceutical production while reducing reliance on overseas manufacturing.

Once fully developed, Callan JMB projects the Atlas Complex could generate more than $430 million in annual revenue while creating hundreds of high-quality jobs and expanding Alabama’s role in the nation’s growing life sciences sector.

“Our vision has always been to create an ecosystem where higher education, innovation, and industry work together,” said Callan JMB CEO Wayne Williams in a statement. “Alabama State University is an exceptional partner as we work to strengthen America’s pharmaceutical capabilities.”

The partnership also builds upon an existing relationship between the university and Callan JMB that began during the COVID-19 pandemic, when the company supported Alabama State’s health and safety initiatives.

ASU President Dr. Quinton T. Ross Jr. said the new agreement gives students meaningful opportunities to gain real-world experience while contributing to one of the country’s fastest-growing industries.

“As a university committed to preparing students to lead, innovate, and serve, Alabama State University is proud to partner with Callan JMB on an initiative that connects education directly with industry,” Ross said.

For HBCUs, partnerships like this continue to demonstrate their growing influence in STEM education, workforce development, and economic innovation. As pharmaceutical manufacturing increasingly returns to the United States, Alabama State is positioning its students to play a key role in shaping the industry’s future.

Story By;

HBCU Original Take: This partnership extends far beyond internships. It places Alabama State University at the center of a major economic development initiative that could create new research opportunities, expand career pathways for students, and strengthen the university’s impact on Alabama’s growing life sciences industry.